Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Jury orders Illumina to pay $96M in patent lawsuit
Yahoo/AP
Friday, March 15, 2013 - 11:14am
tags:
patents, Illumina, Syntrix Biosystems
GlaxoSmithKline CEO says new drugs can be cheaper
Reuters
Friday, March 15, 2013 - 11:12am
tags:
Pharma CEOs, Andrew Witty, GSK, drug pricing
Vanda pulls EU filing for schizophrenia drug
Pharma Times, UK
Friday, March 15, 2013 - 11:11am
tags:
Europe, Vanda, schizophrenia, Fanaptum
FDA seeks to fast track Novartis lung cancer drug
Reuters
Friday, March 15, 2013 - 11:10am
tags:
FDA, fast track, Novartis, non-small cell lung cancer, LDK378
Teva Pays $2.3 Million For Pollution Violations
Pharmalot
Friday, March 15, 2013 - 11:08am
tags:
Teva, drug manufacturing, pollution
Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results
Yahoo
Friday, March 15, 2013 - 11:03am
tags:
earnings, Cardiome
Zogenix Earnings: Here’s Why the Stock is Rising Now
Wall St. Cheat Sheet
Friday, March 15, 2013 - 11:02am
tags:
Zogenix, earnings
Merck anesthesia-reversal agent faces new delay
Reuters
Friday, March 15, 2013 - 11:01am
tags:
Merck, anesthesia reversal, sugammadex
Agilent And The Boom In Companion Diagnostics
Seeking Alpha
Friday, March 15, 2013 - 10:59am
tags:
Agilent, companion diagnostics, Amgen, Eli Lilly, Pfizer
More Good News for Amarin
Motley Fool
Friday, March 15, 2013 - 10:58am
tags:
Amarin, Vascepa
Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise
Seeking Alpha
Friday, March 15, 2013 - 10:57am
tags:
Incivek, Vertex Pharmaceuticals, Gilead, GSK, JNJ, Kalydeco, cystic fibrosis, hepatitis C
J&J Subsidiary Cordis Buys Flexible Stenting Solutions
Motley Fool
Friday, March 15, 2013 - 10:55am
tags:
JNJ, Cordis, stents, Flexible Stenting Solutions, M&A
Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha
Friday, March 15, 2013 - 10:54am
tags:
AntriaBio, AstraZeneca, Novo Nordisk, Sanofi, Bristol-Myers Squibb
Drug Deficit Turning India’s Claris Into Target: Real M&A
Bloomberg
Friday, March 15, 2013 - 10:46am
tags:
Claris Lifesciences, M&A, India, Teva, Pfizer
Sinovac vaccine for hand, foot and mouth disease prevents infection in 95 percent of patients
Yahoo/AP
Thursday, March 14, 2013 - 11:41am
tags:
vaccines, Sinovac, hand foot and mouth disease, EV71
Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech
Thursday, March 14, 2013 - 11:39am
tags:
Navidea Biopharmaceuticals, FDA, breast cancer, Lymphoseek
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thursday, March 14, 2013 - 11:15am
tags:
pancreatic cancer, diabetes, Merck, Januvia, Bristol-Myers Squibb, Byetta, Novo Nordisk, Victoza
Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
Yahoo
Thursday, March 14, 2013 - 11:13am
tags:
earnings, Orexigen
Boehringer signs hep C pact with Presidio
Pharma Times, UK
Thursday, March 14, 2013 - 10:56am
tags:
hepatitis C, Presidio Pharmaceuticals, Boehringer Ingelheim
With Kythera as Model, Lithera Tests Drug to Shrink ‘Love Handles’
Xconomy
Thursday, March 14, 2013 - 10:55am
tags:
Kythera, Lithera, salmeterol xinafoate

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.